53 Comparison of molecular testing strategies in non small cell lung cancer: “reflex” vs “hybrid” approaches

While reflex molecular testing of all non-squamous non-small cell lung carcinomas (NSCLC) is advised there is little data examining the proportion of testing that immediately impacts clinical care leading to concerns over wasted resource. Before 2022 our department adopted a “hybrid” pathologist/multi-disciplinary team-led model where reflex testing was undertaken for patients with stage IV disease and fit for systemic treatment. Testing was also requested later in the event of disease relapse/progression.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Diagnosis and Staging Source Type: research